What is Oruka Therapeutics, Inc.'s unrecognized tax benefits?

Oruka Therapeutics, Inc. (ORKA) reported unrecognized tax benefits of $1.82M in Q4 2025.

Oruka Therapeutics, Inc. ORKA Unrecognized tax benefits

Unrecognized tax benefits at other companies

Thor IndustriesTHO

$12.3M-9.8%

Piper SandlerPIPR

$2.2M+14.8%

Centuri HoldingsCTRI

$0-100%

Liberty GlobalLBTYB

$140.4M-53.3%

Bank of HawaiiBOH

$3.52M-34.1%

GBC

Glacier BancorpGBCI

$0—

Other financials

Income statement

See full

Revenue-—

Operating income-$36.4M-45.2%

Net income-$31.8M-51.5%

EPS (diluted)-$0.46+93.4%

Balance sheet

See full

Cash & equivalents$49.5M-40.7%

Total debt$1.8M+90.8%

Total equity$486.7M+33.4%

Total assets$504.5M+33.8%

Cash flow

See full

Operating cash flow-$23.6M-13.0%

CapEx$73.0K+462%

Free cash flow-$23.7M-13.3%

Valuation

See full

Market cap$5.03B+533%

Returns & leverage

See full

Return on equity-27.3%-11.1pp

Debt / equity0×0.0×

Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefits.

The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s unrecognized tax benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s unrecognized tax benefits?: Oruka Therapeutics, Inc. (ORKA) reported unrecognized tax benefits of $1.82M in Q4 2025.